Chongqing Taiji Industry (Group) operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chongqing Taiji Industry (Group) with three other
companies in this sector in China:
Livzon Pharmaceutical Group Incorporated
sales of 6.62 billion Chinese Renmimbi [US$961.70 million]
of which 39%
was Western Medicine),
Sichuan Kelun Pharmaceutical Company Limited
(7.76 billion Chinese Renmimbi [US$1.13 billion]
of which 98%
was Medical and Pharmaceutical Products), and
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
(7.08 billion Chinese Renmimbi [US$1.03 billion]
of which 62%
was Chinese Medicine).
During the year ended December of 2015, sales at
Chongqing Taiji Industry (Group) were 7.16 billion Chinese Renmimbi (US$1.04 billion).
increase of 3.0%
versus 2014, when the company's sales were 6.95 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Chongqing Taiji Industry (Group)
(and since 2010, sales have increased a total of 20%).
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
47.1% in 2015, from
91.82 million Chinese Renmimbi to 135.06 million Chinese Renmimbi.
Chongqing Taiji Industry (Group) also saw significant increases in sales in
Industrial (up 15.0% to 3.04 billion Chinese Renmimbi)
Not all segments of Chongqing Taiji Industry (Group) experienced an increase in sales in 2015:
sales of Service fell 82.0% to 12.73 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).
Chongqing Taiji Industry (Group) also experienced decreases in sales in
Trading (down 4.2% to 3.98 billion Chinese Renmimbi)